Across Thailand, the number of cats and dogs kept as pets is surging, thanks to a combination of an ageing population and increasing urbanisation. Looking after them has ballooned into an industry worth $2.8bn (£2.2bn) a year — and is set to surge by 10%-15% annually.
Expansion into Asia is expected to be a key source of growth for Dechra Pharmaceuticals, which makes medicines and vaccines specially for pets.
While Dechra does not yet have a presence in southeast Asia, it is thought to be on the lookout for a deal. Chief executive Ian Page has already said he is in the market.
It would be a welcome boost for Dechra, which has endured a rocky few months after a rise in its share price